Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and Distinguished Portfolio
RARITAN, N.J., November 3, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson are committed to redefining treatment outcomes in the hematology setting and today announced that abstracts from more than 50 company-sponsored studies, plus more than 20 investigator-initiated studies, will be presented at the American Society of Hematology (ASH) Annual Meeting in New Orleans from December 10-13, 2022. Janssen’s commitment to advancing an innovative portfolio of therapies for healthcare professionals and patients is evidenced through more than 70 presentations that span clinical studies and r...
Source: Johnson and Johnson - November 3, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
IDSA: Three-Dose Hepatitis B Vaccine Highly Protective in Persons With HIV
WEDNESDAY, Oct. 26, 2022 -- For persons living with HIV (PLWH), a three-dose hepatitis B virus (HBV) vaccine adjuvanted to a TLR-9 agonist (HepB-CpG) yields 100 percent seroprotection, according to a study presented at the annual meeting of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 26, 2022 Category: Pharmaceuticals Source Type: news
Extra Hep B Vaccine Dose Exceeds Expectations for People With HIV
(MedPage Today) -- WASHINGTON -- Three doses of hepatitis B vaccine with a cytosine phosphoguanine adjuvant (HepB-CpG; Heplisav-B) notched a perfect mark when it came to seroprotection for people with HIV who had never before been vaccinated... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - October 24, 2022 Category: Gastroenterology Source Type: news
Panel Votes to Add COVID-19 Shots to Recommended Vaccinations
NEW YORK — COVID-19 shots should be added to the lists of recommended vaccinations for kids and adults, a panel of U.S. vaccine experts said Thursday.
The panel’s unanimous decision has no immediate effect—COVID-19 shots already are recommended for virtually all Americans. Rather, it would put the shots on the annually updated, formal lists of what vaccinations doctors should be routinely offering to their patients, alongside shots for polio, measles and hepatitis.
The expert panel’s decisions are almost always adopted by the CDC director and then sent to doctors as part of the government’s ad...
Source: TIME: Health - October 21, 2022 Category: Consumer Health News Authors: Mike Stobbe/AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news
Three-dose hepatitis B vaccine regimen protects people with HIV
Finding is part of an ongoing clinical trial. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - October 20, 2022 Category: American Health Source Type: news
Results of Novel Clinical Study of Guselkumab and Golimumab Combination Therapy Show Adults with Moderately to Severely Active Ulcerative Colitis Maintained Higher Rates of Clinical, Histologic, and Endoscopic Remission at Week 38
SPRING HOUSE, PENNSYLVANIA, October 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from an ongoing analysis of a Phase 2a clinical trial showing adults with moderately to severely active ulcerative colitis (UC) who received 12 weeks of combination induction therapy with guselkumab and golimumab, followed by a transition to guselkumab alone for maintenance, achieved a clinical remission ratea (based on the modified Mayo score [mMayo])b at week 38 of 47.9 percent, a higher rate than induction and maintenance treatment with either guselkumab alone (31.0 percent) or golimumab al...
Source: Johnson and Johnson - October 10, 2022 Category: Pharmaceuticals Source Type: news
Panacea wins contract worth $127 million from WHO, PAHO to supply pentavalent vaccine
The vaccine protects children against five deadly diseases: Diphtheria, Tetanus, Pertussis, Hepatitis B and invasive infections caused by Haemophilus Influenza Type b. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 10, 2022 Category: Pharmaceuticals Source Type: news
A warming planet could mess with our sleep – and make us more vulnerable to infectious diseases
Key takeaways:Heat spoils sleep. Studies have shown that higher temperatures contribute to sleep disturbance, said Dr. Michael Irwin, who reviewed a wide body of research for the current paper.Poor sleep harms health. Studies also show that a lack of sleep can reduce our immune response and heighten our risk of infection.The big question:Considering these factors, is it possible the ongoing climate crisis may play a role in our susceptibility to COVID-19, monkeypox and other infectious diseases? It ’s a scene that will be familiar for many after yet another scorching summer: You’re lying awake during a warm ...
Source: UCLA Newsroom: Health Sciences - August 24, 2022 Category: Universities & Medical Training Source Type: news
WHO and UDER implement multi-partner project to boost primary health care services in northwest ...
21 August 2022 – WHO, together with the Relief Experts Association UDER as implementing agency, has bolstered the provision of primary health care services in northwest Syria by rendering the facilities in the towns of Sarmada, Tarmanin, Daret Azza and Zarzour fully operational.
Due to the size and scope of the project – which took place between August 2021 and May 2022 – UDER had struck agreements with several other organizations on the ground. Thanks to immense efforts requiring daily coordination, the Mentor Initiative offered leishmaniasis treatment services; Physicians Across Continents delivered mal...
Source: WHO EMRO News - August 21, 2022 Category: Middle East Health Source Type: news
FREE CONTACT HOUR: JHSON Virtual Nursing Grand Rounds
p{
margin:10px 0;
padding:0;
}
table{
border-collapse:collapse;
}
h1,h2,h3,h4,h5,h6{
display:block;
margin:0;
padding:0;
}
img,a img{
border:0;
height:auto;
outline:none;
text-decoration:none;
}
body,#bodyTable,#bodyCell{
height:100%;
margin:0;
padding:0;
width:100%;
}
.mcnPreviewText{
display:none !important;
}
#outlook a{
padding:0;
}
img{
-ms-interpolation-mode:bicubic;
}
table{
mso-table-lspace:0pt;
mso-table-rspace:0pt;
}
.ReadMsgBody{
width:100%;
}
.ExternalClass{
width:100%;
}
p,a,li,td,blockquote{
...
Source: Johns Hopkins University and Health Systems Archive - August 10, 2022 Category: Nursing Source Type: news
Rwanda: Hepatitis - Rwanda on Course to Reach Last Mile
[New Times] The first time Alice Mukabalisa, 53, discovered that she had hepatitis was when she went to take a vaccination shot in 2018. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 5, 2022 Category: African Health Source Type: news
Ghana: 'Ensure Hepatitis Vaccination At Birth'
[Ghanaian Times] A Consultant Gastroenterologist and Physician, DrAdwoaAgyei-Nkansah, has appealed to government to ensure Hepatitis vaccination at birth in the country. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 4, 2022 Category: African Health Source Type: news
The Virus Hunters Trying to Prevent the Next Pandemic
Nobody saw SARS-CoV-2 coming. In the early days of the pandemic, researchers were scrambling to collect samples from people who had mysteriously developed fevers, coughs, and breathing problems. Pretty soon, they realized that the disease-causing culprit was a new virus humans hadn’t seen before.
And the world, lacking a coordinated global response, was unprepared. Some countries acted quickly to develop tests for the novel coronavirus, while others with fewer resources were left behind. With a virus oblivious to national borders, and with travel between countries and continents more common than it had been in previo...
Source: TIME: Health - August 1, 2022 Category: Consumer Health News Authors: Alice Park and Video by Andrew D. Johnson Tags: Uncategorized Disease Frontiers of Medicine 2022 healthscienceclimate Source Type: news
Progress Toward the Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Worldwide, 2016-2021
This report describes global progress towards the elimination of mother-to-child hepatitis B virus. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 28, 2022 Category: American Health Tags: Hepatitis B Hepatitis B Vaccination MMWR Morbidity & Mortality Weekly Report Source Type: news
Ghana: World Hepatitis Day, July 28 (1)
[Ghanaian Times] The burden of hepatitis B infection is highest in the WHO Western Pacific Region and the WHO African Region, where 116 million and 81 million people, respectively, are chronically infected. In 2019, hepatitis B resulted in an estimated 820 000 deaths, mostly from cirrhosis and hepatocellular carcinoma (primary liver cancer). Hepatitis B can be prevented by vaccines that are safe, available and effective. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 28, 2022 Category: African Health Source Type: news
